Drawing on decades of experience in the global pharmaceutical industry, he speaks on:
- the realities of modern drug development
- regulatory strategy and scientific uncertainty
- innovation in life sciences and biotech
- the evolving relationship between evidence, access, policy, and patient impact
- the future of decision-making in medicine
These talks are particularly relevant for pharmaceutical, biotech, healthcare, innovation, and policy audiences.





